fbpx

Dexcom® Continuous Glucose Monitoring (CGMS) System

About: This study is being conducted to find out how safe and accurate different versions of the Dexcom® Continuous Glucose Monitoring (CGMS) System work during activities of daily living at home and in the clinic.

The study requires a time commitment of up to 8 weeks, including screening, 5 outpatient visits and at-home activities.

  • Males or Females
  • Age 18 years or older
  • Diagnosis of type 1 diabetes (T1D) or type 2 diabetes (T2D) and on intensive insulin therapy (IIT) with known dosing parameters for at least three (3) months prior to the Screening Visit.
  • Weigh at least of 110 lbs. (50 kilograms)

The total stipend for this study is up to $990.00 if all study visits are completed. Travel stipends are also available for patients who do not live in the greater San Diego area.